Acrospire Investment Management LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$77,000
+40.0%
6,956
+23.4%
0.07%
+60.0%
Q1 2017$55,000
-62.6%
5,636
-58.7%
0.04%
-25.0%
Q4 2016$147,000
+12.2%
13,630
+6.6%
0.06%
-31.0%
Q3 2016$131,000
+125.9%
12,782
+190.0%
0.09%
+102.3%
Q2 2016$58,000
-43.7%
4,407
-52.9%
0.04%
-39.4%
Q1 2016$103,0009,3600.07%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders